Gary Falk, MD, MS, Professor of Medicine, Director, Center for Esophageal and Swallowing Disorders, Cleveland Clinic, discusses Barrett’s esophagus and its identification and treatment in the primary care…
NEW YORK (Reuters Health) – The tyrosine kinase inhibitor gefitinib is more effective than standard therapy with carboplatin-paclitaxel for lung adenocarcinomas with mutations in the epidermal growth factor…
NEW YORK (Reuters Health) – Roughly 56% of melanomas detected in general dermatology practice are found through full-body skin examinations (FBSE), not as the result of patient complaint,…
NEW YORK (Reuters Health) – In children in the ER, use of ketamine at a high IV dose increases the risks of airway and respiratory events, emesis, and…
NEW YORK (Reuters Health) – The use of ACE inhibitors prior to coronary artery bypass grafting (CABG) is associated with an increased risk of death, need for inotropic…
NEW YORK (Reuters Health) – Five-year survival is similar whether patients with acute MI are treated with primary percutaneous coronary intervention (PCI) or pre-hospital lysis followed by transfer…
NEW YORK (Reuters Health) – Use of 18F-FDG PET imaging can reduce the rate of futile laparotomies in patients with colorectal liver metastases from 45% to 28%, according…
Yan Trokel, MD, Cosmetic Surgeon, Founder and Director, The YAN Center for Corrective & Cosmetic Surgery, discusses the Zerona laser which allows loss of body fat in a…
NEW YORK (Reuters Health) – A meta-analysis of trial data suggests that erythropoietin can be safely used to treat anemia in patients with chronic heart failure and may…
NEW YORK (Reuters Health) – The Institute of Medicine recommends that normal weight women gain 25 to 35 pounds during pregnancy, but now new research indicates that this…
